Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms

被引:39
作者
Callan, Anna Carita [1 ]
Milne, Elizabeth [1 ]
机构
[1] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6872, Australia
关键词
Molecular epidemiology; Insulin-like growth factors; Cancer; PLASMA-PROTEIN-A; FACTOR-BINDING PROTEIN-1; ACUTE LYMPHOBLASTIC-LEUKEMIA; PERINATAL RISK-FACTORS; PROGRAMMED CELL-DEATH; HIGH BIRTH-WEIGHT; FACTOR-II IGF2; WILMS-TUMOR; CORD-BLOOD; AMNIOTIC-FLUID;
D O I
10.1007/s10552-009-9378-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Fetal growth is determined by a complex interplay of genetic, nutritional, environmental, and hormonal factors. Greater than expected fetal growth has been positively associated with the risk of the development of some cancers in childhood, particularly acute lymphoblastic leukemia, and the biological mechanisms underlying such associations are thought to involve insulin-like growth factors (IGFs). Circulating IGF levels are highly correlated with fetal growth, and IGFs are believed to play an important role in carcinogenesis; however, these two bodies of evidence have not been well integrated and, as a result, the potential underlying biological mechanisms linking the IGF system with the development of specific childhood cancers have not been elucidated. This review aims to draw together and summarize the literature linking the IGF system, rapidity of fetal growth, and risk of some specific childhood cancers; suggest explanations for some of the inconsistencies observed in previous studies of these associations; and propose an integrated framework for the putative involvement of the IGF system in the development of at least some childhood cancers. If the challenges involved in studying the complex IGF system can be overcome, this field presents an exciting opportunity to elucidate etiological pathways to childhood malignancies.
引用
收藏
页码:1783 / 1798
页数:16
相关论文
共 162 条
[1]
ALBRECHT S, 1994, CANCER RES, V54, P5041
[2]
Anderson John, 1999, Neoplasia (New York), V1, P340, DOI 10.1038/sj.neo.7900052
[3]
Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia:: A longitudinal study [J].
Argüelles, B ;
Barrios, V ;
Pozo, J ;
Muñoz, MT ;
Argente, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4087-4092
[4]
IGFBP-6 five years on; not so 'forgotten'? [J].
Bach, LA .
GROWTH HORMONE & IGF RESEARCH, 2005, 15 (03) :185-192
[5]
Baik I, 2005, CANCER RES, V65, P358
[6]
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[7]
ONTOGENY OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1, PROTEIN-2, AND PROTEIN-3 - QUANTITATIVE MEASUREMENTS BY RADIOIMMUNOASSAY IN HUMAN FETAL SERUM [J].
BANG, P ;
WESTGREN, M ;
SCHWANDER, J ;
BLUM, WF ;
ROSENFELD, RG ;
STANGENBERG, M .
PEDIATRIC RESEARCH, 1994, 36 (04) :528-536
[8]
THE MOUSE INSULIN-LIKE GROWTH-FACTOR TYPE-2 RECEPTOR IS IMPRINTED AND CLOSELY LINKED TO THE TME LOCUS [J].
BARLOW, DP ;
STOGER, R ;
HERRMANN, BG ;
SAITO, K ;
SCHWEIFER, N .
NATURE, 1991, 349 (6304) :84-87
[9]
Insulin-like growth factor-binding protein-2 levels in pediatric patients with growth hormone deficiency, eating disorders and acute lymphoblastic leukemia [J].
Barrios, V ;
Buño, M ;
Pozo, J ;
Muñoz, MT ;
Argente, J .
HORMONE RESEARCH, 2000, 53 (05) :221-227
[10]
LEVELS OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN HUMAN CORD BLOOD [J].
BENNETT, A ;
WILSON, DM ;
LIU, F ;
NAGASHIMA, R ;
ROSENFELD, RG ;
HINTZ, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (03) :609-612